F.D.A Delays Review of Pfizer’s Covid Vaccine for Children Under 5
The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.
Full Article
F.D.A Delays Review of Pfizer’s Covid Vaccine for Children Under 5
NYTimes.com
0 shares
1 views
You might like
Related news coverage
Pfizer-BioNTech COVID vaccine less effective against infection for kids 5 to 11, study suggests
CBC.ca
Two doses of the Pfizer-BioNTech COVID-19 vaccine was protective against severe disease in children aged five to 11 during the..
-
S. Korea approves Pfizer's COVID vaccine for ages 5-11
SeattlePI.com
-
Qatar - S. Korea approves Pfizer's COVID vaccine for ages 5-11
MENAFN.com
-
Two teenagers drop dead days after getting "vaccinated" with Pfizer – media silent
NaturalNews.com
-
COVID-19 vaccine in pregnancy may protect babies after birth
SeattlePI.com
Advertisement
More coverage
The F.D.A. delays action on Covid shots for young children.
NYTimes.com
In a striking reversal, federal regulators said that they would wait for data on whether three doses of Pfizer-BioNTech’s vaccine..